Time-Restricted Eating for Postpartum Weight Loss
(Time4Mom Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a method called early Time-Restricted Eating (eTRE) to help new mothers with overweight or obesity lose weight after childbirth. Participants eat all meals within a 9-hour window each day, followed by a 15-hour fasting period, and receive support through remote sessions. Mothers who are 6 to 16 weeks postpartum, had a single healthy pregnancy, and have a BMI of 25 or more may qualify. The trial aims to determine if this approach is feasible and acceptable for new mothers. As an unphased study, it offers a unique opportunity to explore a new weight loss method tailored for new mothers.
Will I have to stop taking my current medications?
The trial requires that you do not use any medication expected to significantly impact body weight.
What prior data suggests that this time-restricted eating intervention is safe for postpartum women?
Research shows that early time-restricted eating (eTRE) is generally safe and easy for most people to follow. In studies with groups not specifically including new mothers, this eating pattern has led to noticeable health benefits, such as improved blood pressure and mood. For instance, one study found that eTRE helped people lose weight and lowered their diastolic blood pressure (the bottom number in a blood pressure reading). Another study found that eTRE stabilized blood sugar levels, which benefits overall health.
Although these studies did not specifically focus on new mothers, the consistent positive results suggest that eTRE is safe for most people, including those who have recently given birth. The studies reviewed have reported no serious side effects.12345Why are researchers excited about this trial?
Researchers are excited about time-restricted eating (TRE) for postpartum weight loss because it introduces a novel approach to weight management. Unlike traditional methods like calorie counting or intensive exercise routines, this technique focuses on when you eat rather than what or how much you consume. The early time-restricted eating (eTRE) method specifically involves a 9-hour eating window followed by a 15-hour fasting period, which is thought to align better with the body's natural circadian rhythms. This could potentially result in more effective weight loss and improved metabolic health for new mothers, making it a promising avenue for postpartum weight management.
What evidence suggests that early time-restricted eating is effective for postpartum weight loss?
This trial will compare early time-restricted eating (eTRE) with a control condition for postpartum weight loss. Research has shown that eating within a shorter time frame earlier in the day, known as eTRE, can aid weight loss. People tend to lose more weight with eTRE compared to eating over longer periods, such as 12 hours or more. It also appears to lower blood pressure and improve mood. Many studies suggest that eTRE helps people eat less and aligns eating times with the body's natural clock. These benefits have been observed in various groups, but more research is needed specifically for postpartum women.13678
Who Is on the Research Team?
Camille S Worthington, PhD
Principal Investigator
University of Alabama at Birmingham
Are You a Good Fit for This Trial?
This trial is for postpartum women who are dealing with overweight or obesity. It's designed to see if eating during a specific time frame each day can help with weight loss after having a baby.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either a 9-hour eating/15-hour fasting time-restricted eating intervention or a control group for 12 weeks
Follow-up
Participants are monitored for changes in clinical outcomes and patient-reported outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Early Time-Restricted Eating (eTRE)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator